Whitehawk Therapeutics (WHWK) Capital Expenditures Growth (1y) (2017 - 2025)
Whitehawk Therapeutics (WHWK) Capital Expenditures Growth (1y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Whitehawk Therapeutics |
310.18 Mn |
187.14 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
275.24% |
| Jun 30, 2025 |
-272.30% |
| Mar 31, 2025 |
-25.44% |
| Dec 31, 2024 |
-108.18% |
| Sep 30, 2024 |
145.30% |
| Jun 30, 2024 |
-108.86% |
| Mar 31, 2024 |
90.96% |
| Dec 31, 2023 |
4,835.90% |
| Sep 30, 2023 |
-714.60% |
| Jun 30, 2023 |
5,867.86% |
| Mar 31, 2023 |
1,582.61% |
| Sep 30, 2020 |
59.47% |
| Dec 31, 2019 |
-100.01% |
| Sep 30, 2019 |
-79.50% |
| Mar 31, 2019 |
1,233.05% |
| Dec 31, 2018 |
263.22% |
| Mar 31, 2018 |
284.87% |
| Jun 30, 2017 |
52.35% |
| Mar 31, 2017 |
-98.00% |
